Highlights from the Week of 21st September 2026 - 28th September 2026 ( FDA, Approval ) Mirum obtains FDA approval for ATEBRIOZ tablets to reduce the volume of HO in those aged 12 years and older with FOP ( FDA, Approval ) Lantheus gets final approval from FDA for BRAVNETSA to treat adults with somatostatin receptor-positive GEP-NETs, including foregut, midgut, and hindgut neuroendocrine tumors ( FDA, Approval ) Eli Lilly gains FDA approval for ONSWIK, indicated along with diet and exercise, to control high blood sugar in adults with type 2 diabetes ( FDA, Approval ) FDA grants approval to Elevar Therapeutics' LYRFIGTU as a treatment option for CCA with FGFR2 fusion or other rearrangement Pg 1/5 All logos and trademarks remain the intellectual properties of their respective owners

Highlights from the Week of 21st Sep – 28th Sep in the world of pharma and healthcare!

Uncategorized /

Highlights from the Week of 21st Sep – 28th Sep in the world of pharma and healthcare! Read More »